Christine Mundkur

Christine Mundkur has extensive experience in the pharmaceutical industry, having held various leadership roles throughout their career. Christine served as the CEO of Impopharma, Inc. from February 2013 to February 2017. Prior to that, they were the President and CEO of Sandoz US Inc. from January 2009 to April 2010. Christine also served as the CEO of the Generics Division at Barr Laboratories from March 2008 to December 2008. Christine has also held positions as an Independent Director at Cardinal Health (starting in September 2022), MannKind Corporation (starting in November 2018), and Lupin (from April 2019 to December 2022).

Christine Mundkur attended Saint Louis University from 1986 to 1993. Christine earned a Juris Doctor degree in Law in 1993 and also studied Chemistry, receiving a degree in this field in 1990.